The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT3 receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner

被引:158
作者
Rammes, G
Rupprecht, R
Ferrari, U
Zieglgänsberger, W
Parsons, CG
机构
[1] Max Planck Inst Psychiat, D-80804 Munich, Germany
[2] Merz & Co, D-60318 Frankfurt, Germany
关键词
serotonin; 5-HT3; receptor; ionotropic; recombinant; memantine; patch-clamp;
D O I
10.1016/S0304-3940(01)01872-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The type 3 serotonin (5-HT3) receptor is a ligand-gated ion channel. in concentration-clamp experiments, we investigated the effects of the uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonists memantine, amantadine and MRZ 2/579 on 5-HT receptors stabley expressed in HEK-293 cells and on native 5-HT3 receptors in the N1E-115 cell line. All agents antagonized serotonin (10 muM)-induced inward currents with similar potency to that reported for NMDA receptors. This effect was characterized by inducing a pronounced receptor desensitization, and was probably non-competitive and voltage-independent. In contrast, (S)-ketamine was much weaker as an antagonist of 5-HT3 receptors than NMDA receptors. Similar effects on 5-HT3 receptors have been reported previously for a variety of anti-depressants and it is possible that the clinical anti-depressant effects reported for both memantine and amantadine are mediated, at least in part, by antagonistic effects at 5-HT3 receptors. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:81 / 84
页数:4
相关论文
共 16 条
[1]   5-HT3 receptors in outside-out patches of N1E-115 neuroblastoma cells: Basic properties and effects of pentobarbital [J].
Barann, M ;
Gothert, M ;
Bonisch, H ;
Dybek, A ;
Urban, BW .
NEUROPHARMACOLOGY, 1997, 36 (4-5) :655-664
[2]   THE PSYCHOPHARMACOLOGY OF 5-HT3 RECEPTORS [J].
COSTALL, B ;
NAYLOR, RJ ;
TYERS, MB .
PHARMACOLOGY & THERAPEUTICS, 1990, 47 (02) :181-202
[3]   EFFECTS OF ANTIDEPRESSANTS ON THE INWARD CURRENT MEDIATED BY 5-HT3 RECEPTORS IN RAT NODOSE GANGLION NEURONS [J].
FAN, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (03) :741-744
[4]   Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression [J].
Fawcett, J ;
Barkin, RL .
JOURNAL OF AFFECTIVE DISORDERS, 1998, 51 (03) :267-285
[5]   AN ELECTROPHYSIOLOGICAL INVESTIGATION OF THE PROPERTIES OF A MURINE RECOMBINANT 5-HT3 RECEPTOR STABLY EXPRESSED IN HEK-293 CELLS [J].
GILL, CH ;
PETERS, JA ;
LAMBERT, JJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (06) :1211-1221
[6]   The non-antiemetic uses of serotonin 5-HT3 receptor antagonists - Clinical pharmacology and therapeutic applications [J].
Greenshaw, AJ ;
Silverstone, PH .
DRUGS, 1997, 53 (01) :20-39
[7]   INTERACTIONS BETWEEN 5-HT(3) RECEPTORS AND CEREBRAL DOPAMINE FUNCTION - IMPLICATIONS FOR THE TREATMENT OF SCHIZOPHRENIA AND PSYCHOACTIVE SUBSTANCE-ABUSE [J].
HAGAN, RM ;
KILPATRICK, GJ ;
TYERS, MB .
PSYCHOPHARMACOLOGY, 1993, 112 (01) :S68-S75
[8]  
Kostowski Wojciech, 1996, Polish Journal of Pharmacology, V48, P243
[9]   5-HT3 receptors and the neural actions of alcohols:: an increasingly exciting topic [J].
Lovinger, DR .
NEUROCHEMISTRY INTERNATIONAL, 1999, 35 (02) :125-130
[10]   PHYSIOLOGICAL AND PHARMACOLOGICAL PROPERTIES OF 5-HT3 RECEPTORS - A PATCH CLAMP-STUDY [J].
MALONE, HM ;
PETERS, JA ;
LAMBERT, JJ .
NEUROPEPTIDES, 1991, 19 :25-30